These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 3466690
1. Depletion of sodium butyrate from the culture medium of Friend erythroleukemia cells undergoing differentiation. Friend C, Zajac-Kaye M, Holland JG, Pogo BG. Cancer Res; 1987 Jan 15; 47(2):378-82. PubMed ID: 3466690 [Abstract] [Full Text] [Related]
2. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells. Corin RE, Haspel HC, Peretz AM, Sonenberg M, Rifkind RA. Cancer Res; 1986 Mar 15; 46(3):1136-41. PubMed ID: 3455880 [Abstract] [Full Text] [Related]
3. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers. Chen YL, Wu RT. Cancer Res; 1994 Apr 15; 54(8):2192-8. PubMed ID: 7513611 [Abstract] [Full Text] [Related]
5. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60. Breitman TR, He RY. Cancer Res; 1990 Oct 01; 50(19):6268-73. PubMed ID: 2400989 [Abstract] [Full Text] [Related]
6. Evidence for multiple sites of regulation of heme synthesis in murine erythroleukemia cells. Ebert PS, Bonkowsky HL, Deisseroth A. J Natl Cancer Inst; 1979 May 01; 62(5):1247-50. PubMed ID: 155751 [Abstract] [Full Text] [Related]
8. Differentiation of erythroleukemic cells in vitro: irreversible induction by dimethyl sulfoxide (DMSO). Preisler HD, Giladi M. J Cell Physiol; 1975 Jun 01; 85(3):537-46. PubMed ID: 49357 [Abstract] [Full Text] [Related]
9. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response. Okafuji K, Kaku K, Seguchi M, Tanaka H, Azuno Y, Kaneko T. Exp Hematol; 1995 Mar 01; 23(3):210-6. PubMed ID: 7875239 [Abstract] [Full Text] [Related]
10. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization. Hafid-Medheb K, Poindessous-Jazat V, Augery-Bourget Y, Hanania N, Robert-Lézénès J. Cell Death Differ; 1999 Feb 01; 6(2):166-74. PubMed ID: 10200563 [Abstract] [Full Text] [Related]
12. Growth and differentiation of human and murine erythroleukemia cell lines in serum-free synthetic medium. Pessano S, McNab A, Rovera G. Cancer Res; 1981 Sep 01; 41(9 Pt 1):3592-6. PubMed ID: 7020933 [Abstract] [Full Text] [Related]
13. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Murate T, Yamashita K, Ohashi H, Kagami Y, Tsushita K, Kinoshita T, Hotta T, Saito H, Yoshida S, Mori KJ. Exp Hematol; 1993 Jan 01; 21(1):169-76. PubMed ID: 8417953 [Abstract] [Full Text] [Related]